A phase II study of imatinib mesylate (IM) for patients with advanced melanoma harboring somatic alterations of KIT Meeting Abstract


Authors: Carvajal, R. D.; Chapman, P. B.; Wolchok, J. D.; Cane, L.; Teitcher, J. B.; Lutzky, J.; Pavlick, A. C.; Bastian, B. C.; Antonescu, C. R.; Schwartz, G. K.
Abstract Title: A phase II study of imatinib mesylate (IM) for patients with advanced melanoma harboring somatic alterations of KIT
Meeting Title: 45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 27
Issue: 15 Suppl.
Meeting Dates: 2009 May 29-Jun 2
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2009-05-20
Start Page: 461s
Language: English
ACCESSION: WOS:000276606606017
PROVIDER: wos
Notes: Meeting Abstract: 9001 -- Source: Wos
MSK Authors
  1. Gary Schwartz
    358 Schwartz
  2. Jedd D Wolchok
    628 Wolchok
  3. Richard D Carvajal
    133 Carvajal
  4. Cristina R Antonescu
    606 Antonescu
  5. Paul Chapman
    246 Chapman
  6. Lauren M Cane
    7 Cane